This systematic review demonstrates that the effectiveness of 5-ALA-guided fluorescence in glioma surgery is strongly dependent on WHO grade and variably influenced by IDH mutation status, with markedly reduced detection in many IDH-mutant tumors. The gene discussed is IDH1; the disease is glioma.